Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PODD
- Price
- 312.89
- Stock movement up
- +5.93 (1.85%)
- Company name
- Insulet Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 22.95B
- Ent value
- 23.84B
- Price/Sales
- 12.66
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 54.53
- Forward P/E
- 53.68
- PEG
- -
- EPS growth
- -
- 1 year return
- 33.19%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PODD does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 54.53 |
| Price to OCF | 70.08 |
| Price to FCF | 102.19 |
| Price to EBITDA | 67.47 |
| EV to EBITDA | 70.08 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.66 |
| Price to Book | - |
| EV to Sales | 13.15 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 70.35M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | 6.08 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 757.40M |
| Net receivables | 462.20M |
| Total current assets | 1.86B |
| Goodwill | 51.60M |
| Intangible assets | 105.00M |
| Property, plant and equipment | 0.00 |
| Total assets | 3.03B |
| Accounts payable | 48.20M |
| Short/Current long term debt | 1.01B |
| Total current liabilities | 647.70M |
| Total liabilities | 1.65B |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 322.19 |
| Daily high | 327.38 |
| Daily low | 321.96 |
| Daily Volume | 477K |
| All-time high | 352.82 |
| 1y analyst estimate | 373.58 |
| Beta | 1.38 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PODD | S&P500 | |
| Current price drop from All-time high | -11.32% | -5.07% |
| Highest price drop | -30.61% | -19.00% |
| Date of highest drop | 17 Oct 2024 | 8 Apr 2025 |
| Avg drop from high | -14.46% | -2.73% |
| Avg time to new high | 30 days | 6 days |
| Max time to new high | 215 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
22.95B
Marketcap category
Large-cap
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Employees
3900
Website
Investor relations
-
SEC filings
CEO
Shacey Petrovic
Country
USA
City
Acton
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page